Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries

ConclusionsMCL included in trials are highly selected patients who are not representative of MCL patients who are encountered in everyday practice. With widened inclusion criteria, clinical trial patients could be more representative of the general population.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research